Research Roundup


health professional at computer with magnifying glass

Debbie Rigby rounds up the latest in research news

Reducing Medical Admissions and Presentations Into Hospital through Optimising Medicines (REMAIN HOME)

Integrating pharmacists into 14 general practices to review medicine management of patients recently discharged from hospital demonstrates patients are 31% less likely to be readmitted or represent to hospital at 12 months and 64% less likely at 30 days. This study shows the value of a collaborative pharmacist‒GP model of post‐hospital discharge medicines management to reduce the incidence of hospital re‐admissions and ED presentations, achieving substantial cost savings to the health system.

Med J Aust, published online: 22 February 2021.

InSight

Are Older People Aware of Potential Risks Related to Benzodiazepines

This Finnish study investigated how well older people are aware of the potential risks related to the BZD they are taking and whether the risk awareness has changed in the years between 2004 and 2015. Awareness on the risks of dependence, interaction with alcohol, dizziness and developing tolerance had improved, but there was no change in awareness on the risk of withdrawal symptoms, falls, depression, muscle weakness, reduced psychomotor performance and memory, and do not aid sleep with long-term use.

Patient Preference and Adherence 2021;15:41–147.

A Pilot Australian Pharmacist Health Coaching Trial of Participants with Poorly Controlled Hypertension

This study provides the perspective of the stakeholders involved in pharmacist health coaching interventions. Pharmacist health coaching strengthened participant interest and health confidence. Participants were initially uncertain about the causes of and the clinical targets for hypertension. Pharmacist health coaching improved participant’s health knowledge and progress.

Patient Preference and Adherence 2021;15:127–140.

Non-steroidal anti-inflammatory drugs (NSAIDs) for musculoskeletal pain

Oral non-steroidal anti-inflammatory drugs (NSAIDs) can reduce musculoskeletal pain but increase the risk of gastrointestinal (perforation, ulcers, bleeding), cardiovascular (myocardial infarction, heart failure, hypertension), and renal adverse events. Topical NSAIDs are also effective for osteoarthritis, with fewer adverse events than oral formulations. Opioids do not provide greater pain relief than NSAIDs for musculoskeletal pain and may cause serious harms such as dependence.

BMJ 2021;372:n104

Previous Check your mailbox
Next Benzos, stimulants commonly co-ingested with quetiapine

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.